Mountain View, CA, United States of America

Erik E Karrer

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 6.5

ph-index = 6

Forward Citations = 71(Granted Patents)


Location History:

  • Fremont, CA (US) (2012)
  • Mountain View, CA (US) (2010 - 2013)
  • Los Altos, CA (US) (2012 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Erik E Karrer: Innovator in Antibody Therapeutics

Introduction

Erik E Karrer is a prominent inventor based in Mountain View, CA, with a remarkable portfolio of 14 patents. His work primarily focuses on the development of innovative antibody therapies aimed at treating various diseases by modulating immune responses.

Latest Patents

Among his latest patents is the invention of Anti-CD200R1 antibodies and methods of use thereof. This patent provides binding proteins, such as antibodies and antigen-binding fragments, that specifically bind to the human CD200R1 receptor protein. These antibodies are capable of decreasing, inhibiting, and fully blocking immune regulatory effects mediated by hu-CD200R1. Additionally, Karrer has developed a method of treating asthma with anti-IL1RAP antibodies. This invention offers binding proteins that specifically bind to the human interleukin-1 receptor accessory protein, effectively blocking the IL-1, IL-33, and IL-36 intracellular signaling pathways.

Career Highlights

Throughout his career, Erik E Karrer has made significant contributions to the field of biotechnology. He has worked with notable companies such as Perseid Therapeutics LLC and 23andMe, Inc., where he has applied his expertise in antibody development and therapeutic applications.

Collaborations

Karrer has collaborated with esteemed colleagues, including Steven Henry Bass and Madan M Paidhungat, further enhancing his innovative work in the field of antibody therapeutics.

Conclusion

Erik E Karrer stands out as a leading inventor in the biotechnology sector, with a focus on antibody therapies that have the potential to transform treatment options for various diseases. His contributions continue to shape the landscape of immunology and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…